Denosumab and fracture risk in women with breast cancer Reply

被引：4
|
作者：
Gnant, Michael [1 ]
机构：
[1] Med Univ Vienna, Dept Surg, A-1090 Vienna, Austria
来源：
LANCET | 2015年 / 386卷 / 10008期
关键词：
POSTMENOPAUSAL WOMEN; CONTROLLED-TRIAL; PREVENTION;
D O I：
10.1016/S0140-6736(15)00975-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2057 / 2058
页数：2
相关论文
共 50 条
  • [1] Denosumab and fracture risk in women with breast cancer
    Coleman, Robert
    Hadji, Peyman
    LANCET, 2015, 386 (9992) : 409 - 410
  • [2] Persistence with Denosumab in Women at High Risk of Fracture in Bulgaria
    Monov, Simeon
    Nestorova, Rodina
    Velkova, Margarita
    Boyanov, Mihail
    Jeleva, Silvia
    Petkova, Renata
    Petranova, Tzvetanka
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 443 - 455
  • [3] Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study
    Giannakeas, Vasily
    Cadarette, Suzanne M.
    Ban, Joann K.
    Lipscombe, Lorraine
    Narod, Steven A.
    Kotsopoulos, Joanne
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 1421 - 1427
  • [4] Increased fracture rate in women with breast cancer: a review of the hidden risk
    Body, Jean-Jacques
    BMC CANCER, 2011, 11
  • [5] Fracture risk in women with breast cancer: A population-based study
    Melton, L. Joseph, III
    Hartmann, Lynn C.
    Achenbach, Sara J.
    Atkinson, Elizabeth J.
    Therneau, Terry M.
    Khosla, Sundeep
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (05) : 1196 - 1205
  • [6] Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors
    Mazziotti, Gherardo
    Pedersini, Rebecca
    Vena, Walter
    Cosentini, Deborah
    Carrone, Flaminia
    Pigni, Stella
    Simoncini, Edda L.
    Torrisi, Rosalba
    Zambelli, Alberto
    Farina, Davide
    Balzarini, Luca
    Lania, Andrea G.
    Berruti, Alfredo
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (05) : 466 - 474
  • [7] Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors
    Antonini, S.
    Pedersini, R.
    Birtolo, M. F.
    Baruch, N. L.
    Carrone, F.
    Jaafar, S.
    Ciafardini, A.
    Cosentini, D.
    Lagana, M.
    Torrisi, R.
    Farina, D.
    Leonardi, L.
    Balzarini, L.
    Vena, W.
    Bossi, A. C.
    Zambelli, A.
    Lania, A. G.
    Berruti, A.
    Mazziotti, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (02) : 433 - 442
  • [8] Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial
    Miyauchi, Akimitsu
    Hamaya, Etsuro
    Yang, Wenjing
    Nishi, Kiyoshi
    Libanati, Cesar
    Tolman, Cae
    Shimauchi, Junichiro
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 278 - 288
  • [9] Alcohol and risk of breast cancer in Mexican women
    Beasley, Jeannette M.
    Coronado, Gloria D.
    Livaudais, Jennifer
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Romieu, Isabelle
    Lazcano-Ponce, Eduardo
    Torres-Mejia, Gabriela
    CANCER CAUSES & CONTROL, 2010, 21 (06) : 863 - 870
  • [10] Denosumab in breast cancer treatment
    Drooger, Jan C.
    van der Padt, Annemieke
    Sleijfer, Stefan
    Jager, Agnes
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 717 (1-3) : 12 - 19
12345